Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Precision oncology testing156.23M92.72%
Development services and other12.26M7.28%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States526.52M93.36%
International37.42M6.64%